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background: Measuring fractional flow reserve (FFR) in acute coronary syndromes (ACS) is seldom employed given concerns about 
possible impaired microvascular function. The importance of ischemic reduction assessed by post-stenting FFR (PS-FFR) and its impact 
on long term outcomes has not been studied in this population.
methods: Of 538 consecutive patients undergoing PS-FFR following angiographically successful PCI of a functionally significant lesion, 
176 patients (33%) had ACS. Clinical and angiographic determinants of ischemia reduction and long term outcomes were recorded.
results: Of 176 patients with ACS (age 63+/-10 years, 47% diabetics), 65 patients had NSTEMI and 111 unstable angina. PCI lead 
to angiographic lesion reduction from 76+13% to 1.2+6% with significant ischemia reduction from baseline FFR 0.63+-0.15 to PS-
FFR 0.90+0.6 (p<0.0001). PS-FFR identified 23 patients (13%) who had persistent ischemia (<0.80) despite angiographically optimal 
results. The low FFR prompted a subsequent intervention including post dilation or placement of another stent improving FFR on repeat 
measurement (0.73 +0.06 to 0.85+ 0.05; P<0.0001). The clinical utility of PS-FFR was similar for patients with NSTEMI and unstable 
angina. ROC analysis identified a cutoff of 0.86 for PS-FFR for MACE prediction in ACS population at a mean follow up of 2.7(+ 1.4) years
Conclusion:  PS-FFR is a very robust tool in assessing the degree of ischemic reduction in patients with ACS.
